Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

LISCOMF

Financiado

Cerrado

Light induced spatiotemporal control of membrane fusion for targeted therapy

Targeted therapy remains one of the greatest challenges in modern medicine. In response, I propose synthetic, liposomal vectors capable of delivering diverse and clinically relevant therapies to targeted sites in the body, whose t... ver más

30/09/2015

ULEI

176K€

Presupuesto del proyecto: 176K€

Líder del proyecto

UNIVERSITEIT LEIDEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-09-30 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

ULEI

0.00€ | Lider

Proyectos interesantes

PID2021-122212OA-I00

Medical Technol...

Nanotechnology

97K€ Cerrado

BIOMAP

Medical Technol...

Applied Physics

210K€ Cerrado

IJC2020-043482-I

Medical Technol...

Applied Physics

31K€ Cerrado

MultiTheranostic

Medical Technol...

Nanotechnology

Cerrado

Melomanes

Medical Technol...

Nanotechnology

Cerrado

GLIOMADDS

Medical Technol...

Biotechnology

1M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

UNIVERSITEIT LEIDEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 176K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Targeted therapy remains one of the greatest challenges in modern medicine. In response, I propose synthetic, liposomal vectors capable of delivering diverse and clinically relevant therapies to targeted sites in the body, whose therapeutic action is triggered exclusively by applied light. This approach challenges traditional approaches to targeted vector-based therapies and addresses the common failings of existing technologies. The use of light as a stimulus for therapy makes this technology ideally suited to the treatment of skin disorders, including melanoma and non-melanoma skin cancers, dominant negative genetic disorders, infection and inflammation. In execution, the interdisciplinary research program will be a logical and through progression from organic chemistry to cell culture lab and will be underpinned by foreseen pan-European collaboration. The 2-year program will validate the proposed vector as a viable technology for future animal studies and I expect to be in a strong position to apply for follow-up funding following the Fellowship. My 5-year career goal is to establish my own independent research group at one of Europe’s top university backed by long-term and prestigious funding. To achieve this, I must be able to demonstrate: 1) Practical experience across a wide range of disciplines spanning chemistry and biology, 2) Project leadership, 3) People management and mentoring skills, 4) Exposure to and experience of the relationship between academic and commercial sectors, 5) A strong track record of publication and grant applications, 6) Presentation skills, and 7) Demonstrated track record of working effectively in cross-discipline and international collaborations. This proposal has been carefully designed to provide me with all these attributes, putting me in the strongest possible position to achieve my future career ambitions.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores